Back to Search
DANIEL SUNDIN, PHD
PHD
Clinical Laboratory Director (Non-physician)
NPI: 1295866721Individual
Specialties, Licenses & Credentials
Clinical Laboratory Director (Non-physician)Primary
Technician, Pathology — Clinical Laboratory Director, Non-physician
Code: 247ZC0005X
Research & Publications (20)
Critical, post-structural, interpretive interactionism: an update on Denzin's methodology.
PMID 19025103·Nurse Res·2008
6-review
Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome.
PMID 11752029·J Am Soc Nephrol·2002
8-other
The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes.
PMID 19566927·Crit Care·2009
4-observational
The nuchal cord at birth: what do midwives think and do?
PMID 19397163·Midwifery Today Int Midwife·2009
8-other
Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion.
PMID 19309473·Transfusion·2009
8-other
An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment.
PMID 18248574·Vox Sang·2008
8-other
Analysis of efficacy and safety of drotrecogin alfa (activated) in surgical patients, using an international integrated database.
PMID 17723900·Surgery·2007
8-other
Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated).
PMID 17556722·Am J Respir Crit Care Med·2007
3-trial
Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial.
PMID 17350452·Lancet·2007
3-trial
Alpha1-antitrypsin single dose adjuvant therapy for acute otitis media.
PMID 16815194·Otolaryngol Head Neck Surg·2006
4-observational
Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome.
PMID 16780598·Crit Care·2006
4-observational
Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis.
PMID 16684364·Crit Care·2006
4-observational
An inhaled matrix metalloprotease inhibitor prevents cigarette smoke-induced emphysema in the mouse.
PMID 17146995·COPD·2005
7-preclinical
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment.
PMID 16215381·Crit Care Med·2005
3-trial
Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.
PMID 15550023·J Thromb Haemost·2004
8-other
Protease inhibitors alpha1-antitrypsin and ilomastat are not ototoxic in the chinchilla.
PMID 14520103·Laryngoscope·2003
7-preclinical
Alpha 1-antitrypsin and ilomastat inhibit inflammatory proteases present in human middle ear effusions.
PMID 12897557·Laryngoscope·2003
8-other
Clusterin protects renal tubular epithelial cells from gentamicin-mediated cytotoxicity.
PMID 11880332·Am J Physiol Renal Physiol·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 100 MICHIGAN ST NE
GRAND RAPIDS, MI 49503 - Phone
- (616) 391-2685
Quick Facts
- NPI
- 1295866721
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile